Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder

When behavioral therapies have failed and pharmacologic treatment of OAB/DO is considered, providers should counsel on the associated risk of cognitive impairment, dementia, and Alzheimer disease associated with anticholinergic medications in comparison with the potential benefits related to improvement in quality of life for the individual patient.